Philip M Laws

16PUBLICATIONS
51CO-AUTHORS
Medical infection agents (incl. prions)Rheumatology and arthritisToxicology (incl. clinical toxicology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 15, 2026
Risks of tuberculosis, meningitis, candidiasis, and fungal infections among patients receiving systemic treatments for psoriasis: a nationwide cohort study from BADBIR data.

|Jun 23, 2026
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

|May 04, 2026
Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

|Mar 16, 2026
Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Duc Binh Phan, Philip Laws, Catherine H Smith

|Aug 13, 2025
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral route.

Katya Meridor, Stephanie R Harrison, Gabriele De Marco

|May 22, 2025
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort.

Oras A Alabas, Ian Evans, Kathleen Mcelhone

Pageof 3

Frequent Collaborators

8 joint publications

Richard Warren

8 joint publications

Zenas Z N Yiu

5 joint publications

Heber Rew Bright Bright

3 joint publications

Helena Marzo-Ortega